| ADR Ontology |
| ADR Term |
Meningitis cryptococcal |
| ADR ID |
BADD_A02714 |
| ADR Hierarchy |
|
| Description |
Meningeal inflammation produced by CRYPTOCOCCUS NEOFORMANS, an encapsulated yeast that tends to infect individuals with ACQUIRED IMMUNODEFICIENCY SYNDROME and other immunocompromised states. The organism enters the body through the respiratory tract, but symptomatic infections are usually limited to the lungs and nervous system. The organism may also produce parenchymal brain lesions (torulomas). Clinically, the course is subacute and may feature HEADACHE; NAUSEA; PHOTOPHOBIA; focal neurologic deficits; SEIZURES; cranial neuropathies; and HYDROCEPHALUS. (From Adams et al., Principles of Neurology, 6th ed, pp721-2) [MeSH] |
| MedDRA Code |
10027209 |
| MeSH ID |
D016919
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Cryptococcal meningitis | Cryptococcus neoformans meningitis | Meningitis cryptococcal | Meningitis torula | Cryptococcal meningitis recurrent | Meningitis, Cryptococcal | Cryptococcal Meningitides | Meningitides, Cryptococcal | Cryptococcal Meningitis | Granulomous Cerebral Cryptococcosis | Cerebral Cryptococcoses, Granulomous | Cerebral Cryptococcosis, Granulomous | Cryptococcoses, Granulomous Cerebral | Cryptococcosis, Granulomous Cerebral | Granulomous Cerebral Cryptococcoses | Toruloma | Torulomas | Cerebral Cryptococcosis | Cerebral Cryptococcoses | Cryptococcoses, Cerebral | Cryptococcosis, Cerebral |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
|
|
